Case File
efta-01373973DOJ Data Set 10OtherEFTA01373973
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01373973
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Wayne Salit
Sent:
12/22/2014 1:06:13 PM
To:
John-A Lynch
Subject:
FW: Southern Financial LLC EDD IC)
Classification: Confidential
John -
Kind Regards,
Wayne Salit
From: Dmitri Saks
Sent: Friday, December 19, 2014 11:17 AM
To: Wayne Salit
Subject: Southern Financial LLC - EDD [C]
Classification: Confidential
Wayne,
Enhanced Due Diligence was conducted on Southern Financial LLC, a Private Investment Vehicle incorporated in the U.S.
Virgin Islands, which is a Level II country, as the result of a New Client Adoption request to open a Global Markets
relationship. The below is for your review and approval.
Nature of Escalation —
•
The escalation is due to the client being a Private Investment Vehicle, which is considered High risk.
Note: The documentation for this account is available for review on the shared drive via the following path:
LACentral_Functions_Compliance \Comp-nyseccom \ Varela \ AML\ Pending Investigations, EDD, EDRs\Southern Financial
LLC\
Research Findings (LEXIS/GOOGLE SEARCHES) —
•
Southern Financial LLC is a private investment vehicle incorporated under the laws of the Virgin Islands of the
United States. The sole member of Southern Financial LLC is Southern Trust Company, Inc. which is also incorporated in
the U.S. Virgin Islands. The sole shareholder of Southern Trust Company, Inc. is Jeffrey Edward Epstein.
Ownership/UBOs —
•
Jeffrey Edward Epstein is the sole U8O and a control person of Southern Financial LLC. He is an American financier
and science and education philanthropist. He began his financial career in 1976 as an options trader at Bear Stearns and
became a partner in 1980. In 1982, Epstein founded his own financial management firm, J. Epstein & Co., managing the
assets of clients with more than a billion in net worth. In 1996, Epstein changed the name of his firm to The Financial
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0068439
CONFIDENTIAL
SDNY_GM_00214623
EFTA01373973
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.